HEPION PHARMACEUTICALS INC (HEPA)
US4268973025 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 14.79M | 51.20M | 91.30M | 40.70M | 13.90M | |||
| Other Current Assets | 2.70M | 5.30M | 6.10M | 1.90M | 500.00K | |||
| Total Current Assets | 17.49M | 56.50M | 97.50M | 42.60M | 14.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 242.37K | 100.00K | 500.00K | 700.00K | 900.00K | |||
| Goodwill | N/A | 0.00 | 1.90M | 1.90M | 1.90M | |||
| Intangibles | 0.00 | 3.20M | 3.20M | 3.20M | 3.20M | |||
| Other Non-Current Assets | 364.19K | 400.00K | 600.00K | 300.00K | 300.00K | |||
| Total Non-Current Assets | 606.56K | 3.70M | 6.10M | 6.00M | 6.20M | |||
| TOTAL ASSETS | 18.09M | 60.20M | 103.60M | 48.60M | 20.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 2.56M | 4.90M | 2.80M | 900.00K | 700.00K | |||
| Accounts Payable | 2.35M | 2.70M | 2.40M | 3.70M | 500.00K | |||
| Other Current Liabilities | 386.00K | 400.00K | 3.00M | 0.00 | 400.00K | |||
| Total Current Liabilities | 5.29M | 7.90M | 8.20M | 4.70M | 1.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 200.00K | 0.00 | |||
| Deferred Taxes/Income | 0.00 | 400.00K | 400.00K | 400.00K | 400.00K | |||
| Other Non-Current Liabilities | 5.52M | 2.10M | 1.90M | 2.90M | 3.00M | |||
| Total Non-Current Liabilities | 5.52M | 2.50M | 2.40M | 3.40M | 3.40M | |||
| TOTAL LIABILITIES | 10.81M | 10.40M | 10.60M | 8.10M | 5.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -224.63M | -175.70M | -133.50M | -104.10M | -83.80M | |||
| Additional Paid In Capital | 230.29M | 223.90M | 224.80M | 142.90M | 97.70M | |||
| Common Shares | 1.70M | 1.70M | 1.70M | 1.70M | 1.70M | |||
| Other Shareholders' Equity | -78.78K | -100.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 4.82M | 3.80M | 3.80M | 1.60M | 200.00K | |||
| Tangible Book Value per Share | 1.16 | 11.84 | 22.68 | 21.06 | 44.00 | |||
| Total Shareholders' Equity | 7.28M | 49.90M | 93.00M | 40.50M | 15.60M | |||
| TOTAL LIABILITIES AND EQUITY | 18.09M | 60.20M | 103.60M | 48.60M | 20.60M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.00 | N/A | |||
| Current Ratio | 3.31 | 7.15 | 11.89 | 9.06 | 9.00 | |||
| Return On Assets (ROA) | -270.39% | -75.32% | -31.58% | -41.89% | -60.58% | |||
| Return On Equity (ROE) | -671.99% | -90.86% | -35.18% | -50.27% | -80.00% | |||
All data in USD